q-bio.BMNov 13, 2026

Multi-Assay Antibody Developability Prediction with Shared Structure-Language Representations

Authors: Daria B. Kokh

Abstract

Early assessment of antibody developability is critical in drug discovery, but computational approaches remain limited by the scarcity of experimental data. We explore two strategies for working within that limit. First, we designed per-residue physicochemical descriptors encoding the local structural environment, including new terms such as directional charge asymmetry and screened electrostatic potential. These feed a convolutional network, combined with protein language model (PLM) embeddings in a two-stream architecture: the two are encoded and predicted independently and merged only at the prediction stage. Second, a shared trunk with per-assay heads passes information between related assays. Both are implemented in the Multi-Assay Developability Model (MADM) and evaluated on eight assays: HIC, heparin affinity (HAC), AC-SINS, and polyspecificity ELISA against BVP, dsDNA, insulin, ovalbumin and soluble membrane proteins (SMP), with labels from 29 open sources. Structural descriptors match or exceed PLM embeddings (AbLang2, ESM2) on several assays; combining the streams gives a small but consistent gain in accuracy and reduces seed-to-seed variance. Multi-assay training raises Spearman rho for ovalbumin and SMP by about 0.1, where assays correlate and share sequence space. Under cluster-split cross-validation the strongest results are for HAC, ovalbumin, insulin, SMP and HIC (rho = 0.70-0.82); AC-SINS, BVP and dsDNA are weaker (0.50-0.55). In these three, sequence clusters largely coincide with data source, so a held-out fold measures transfer to differently calibrated measurements as well as to new sequences. On the 80-antibody GDPa3 hold-out, performance falls by rho around 0.1 for all but SMP (0.22). Transfer to the VHH panel of Ginkgo GDPa5 gives comparable results, and scFv validation against binary SMP labels yields F1 = 0.89, AUC = 0.95.

Explore similar work

Apr 10, 2026

Biologically-Grounded Multi-Encoder Architectures as Developability Oracles for Antibody Design

Generative models can now propose thousands of de novo antibody sequences, yet translating these designs into viable therapeutics remains constrained by the cost of biophysical characterization. Here we present CrossAbSense, a framework of property-specific neural oracles that combine frozen protein language model encoders with configurable attention decoders, identified through a systematic hyperparameter campaign totaling over 200 runs per property. On the GDPa1 benchmark of 242 therapeutic IgGs, our oracles achieve notable improvements of 12--20% over established baselines on three of five developability assays and competitive performance on the remaining two. The central finding is that optimal decoder architectures invert our initial biological hypotheses: self-attention alone suffices for aggregation-related properties (hydrophobic interaction chromatography, polyreactivity), where the relevant sequence signatures -- such as CDR-H3 hydrophobic patches -- are already fully resolved within single-chain embeddings by the high-capacity 6B encoder. Bidirectional cross-attention, by contrast, is required for expression yield and thermal stability -- properties that inherently depend on the compatibility between heavy and light chains. Learned chain fusion weights independently confirm heavy-chain dominance in aggregation (wH=0.62w_H = 0.62) versus balanced contributions for stability (wH=0.51w_H = 0.51). We demonstrate practical utility by deploying CrossAbSense on 100 IgLM-generated antibody designs, illustrating a path toward substantial reduction in experimental screening costs.
May 27, 2026

Computational Modeling of Antibody-Antigen Complexes: PLM-Based and MSA-Based Approaches

Antibodies play a central role in the immune response by specifically recognizing and neutralizing antigens, and therapeutic antibodies have become major drugs for cancer and autoimmune diseases. However, their discovery still relies on extensive in vitro screening, and accurate computational modeling of antibody structures and antibody-antigen interactions can prioritize candidates, reduce experimental burden, and accelerate rational design. Despite recent advances in high-accuracy protein and complex prediction, a persistent performance gap remains for antibody-related tasks compared with general protein-protein interactions, limiting downstream design. This thesis investigates why antibody-related tasks are harder and proposes improvements along two complementary directions. First, we investigate protein language model (PLM)-based methods for antibody and antibody-antigen structure prediction. Using embeddings from multiple PLMs, our approach achieves the best CDR-H3 accuracy among compared PLM-based methods on antibody monomer prediction. Extending it to complex prediction does not generalize: without co-evolutionary signals between antibody and antigen, single-sequence PLM representations do not reliably identify binding interfaces. Second, we develop two MSA-based interventions for antibody-antigen complex prediction: MSA refinement, which combines CDR-focused filtering with depth recovery from a larger sequence database, and convergence-aware recycling, which selects a stable intermediate recycle state for final diffusion sampling. Together, these interventions provide consistent gains over the AlphaFold3 baseline on a held-out antibody-antigen test set. Because the methods modify MSA construction and recycling behavior rather than model parameters, they apply without retraining or weight access.
Dec 26, 2025

DuaDeep-SeqAffinity: Dual-Branch Deep Learning for Tri-Stream Sequence-Based Antibody--Antigen Affinity Prediction

DuaDeep-SeqAffinity is a sequence-only deep learning framework that predicts antibody--antigen binding affinity directly from primary amino acid sequences, avoiding the cost and scarcity of resolved three-dimensional structures. The antigen and the antibody heavy and light chains are processed as three independent streams, each embedded with a frozen ESM-2 protein language model and passed through parallel Transformer and convolutional neural network (CNN) branches before late fusion, a decoupled design intended to preserve local complementarity-determining region (CDR) signal that monolithic encoders can dilute. On a sequence-disjoint split of the AbRank benchmark, the model achieves a Pearson correlation of 0.683, an R^2 of 0.460, and a pairwise ranking AUC of 0.895, significantly outperforming single-branch ablations (paired t-test, p < 0.05). Attention-map and gradient-based saliency analyses further show that the model preferentially attends to CDR loops and candidate epitope residues, supporting its use as a scalable, structure-free tool for high-throughput antibody screening.